Top

Published in:

01-01-2019 | Letter to the Editor

Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient

Authors: Clemens Hinterleitner, Martina Steurer, Daniela Dörfel, Jonas Heitmann, Klaus-Peter Kreisselmeier, Karin Müller, Hans-Georg Kopp, Stefan Wirths, Michael Haap, Leticia Quintanilla-Martinez de Fend, Marius Horger, Carlos Rodriguez-Galindo, Lothar Kanz, Martin R. Müller

Published in: Annals of Hematology | Issue 1/2019

Excerpt

Dear Editor, …

Rosai J, Dorfman RF (1969) Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol 87(1):63–70PubMed

Foucar E, Rosai J, Dorfman R (1990) Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol 7(1):19–73PubMed

Cai Y, Shi Z, Bai Y (2017) Review of Rosai-Dorfman disease: new insights into the pathogenesis of this rare disorder. Acta Haematol 138(1):14–23CrossRefPubMed

Jacobsen E, Shanmugam V, Jagannathan J (2017) Rosai-Dorfman disease with activating KRAS mutation—response to cobimetinib. N Engl J Med 377(24):2398–2399CrossRefPubMed

Oka M et al (2009) Successful treatment of Rosai-Dorfman disease with low-dose oral corticosteroid. J Dermatol 36(4):237–240CrossRefPubMed

Dalia S, Sagatys E, Sokol L, Kubal T (2014) Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment. Cancer Control 21(4):322–327CrossRefPubMed

Zhao M, Li C, Zheng J, Yu J, Sha H, Yan M, Jin J, Sun K, Wang Z (2013) Extranodal Rosai-Dorfman disease involving appendix and mesenteric nodes with a protracted course: report of a rare case lacking relationship to IgG4-related disease and review of the literature. Int J Clin Exp Pathol 6(11):2569–2577PubMedPubMedCentral

Scheel MM, Rady PL, Tyring SK, Pandya AG (1997) Sinus histiocytosis with massive lymphadenopathy: presentation as giant granuloma annulare and detection of human herpesvirus 6. J Am Acad Dermatol 37(4):643–646CrossRefPubMed

Pagel JM, Lionberger J, Gopal AK, Sabath DE, Loeb K (2007) Therapeutic use of rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Am J Hematol 82(12):1121–1122CrossRefPubMed

10.

Lohr HF et al (1995) Long-term survival in a patient with Rosai-Dorfman disease treated with interferon-alpha. Eur J Cancer 31a(13–14):2427–2428CrossRefPubMed

11.

Maia RC, de Meis E, Romano S, Dobbin JA, Klumb CE (2015) Rosai-Dorfman disease: a report of eight cases in a tertiary care center and a review of the literature. Braz J Med Biol Res 48(1):6–12CrossRefPubMed

12.

Cao XX, Sun J, Li J, Zhong DR, Niu N, Duan MH, Liang ZY, Zhou DB (2016) Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults. Ann Hematol 95(5):745–750CrossRefPubMed

13.

Go H, Jeon YK, Huh J, Choi SJ, Choi YD, Cha HJ, Kim HJ, Park G, Min S, Kim JE (2014) Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms. Histopathology 65(2):261–272CrossRefPubMed

14.

Simko SJ, Tran HD, Jones J, Bilgi M, Beaupin LK, Coulter D, Garrington T, McCavit TL, Moore C, Rivera-Ortegón F, Shaffer L, Stork L, Turcotte L, Welsh EC, Hicks MJ, McClain KL, Allen CE (2014) Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease. Pediatr Blood Cancer 61(3):479–487CrossRefPubMed

15.

Eckstein O, Bingham R, Peckham EC, Brown A, Allen CE, McClain KL (2016) Efficacy and toxicity profile of clofarabine in patients with recurrent/refractory Langerhans cell histiocytosis and other histiocytic disorders. Blood 128:1329CrossRef

Title: Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient
Authors: Clemens Hinterleitner
Martina Steurer
Daniela Dörfel
Jonas Heitmann
Klaus-Peter Kreisselmeier
Karin Müller
Hans-Georg Kopp
Stefan Wirths
Michael Haap
Leticia Quintanilla-Martinez de Fend
Marius Horger
Carlos Rodriguez-Galindo
Lothar Kanz
Martin R. Müller
Publication date: 01-01-2019
Publisher: Springer Berlin Heidelberg
Published in: Annals of Hematology / Issue 1/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-018-3421-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2019

Intensive care unit admission in patients with T cell lymphomas: clinical features and outcome

MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type

Acute myeloid leukemia with t(19;21)(q13;q22) and marked eosinophilia

Cytotoxic T-lymphocyte-associated antigen 4-positive aggressive adult T cell leukemia/lymphoma

Major bleeding in a patient with warfarin-hypersensitive and factor IX propeptide variant, p.Ala37Thr, who was treated with a direct oral anti-Xa inhibitor

Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page